Alzheimer's & Dementia · Oct 2025
Higher vitamin B₁₂ from mid- to late life is related to slower rates of cognitive decline
By Marino FR, Rogers G, Miller JW et al.
INTRODUCTION: Evidence is needed to evaluate whether low vitamin B₁₂ from mid- to late life, either alone or in the presence of elevated folate, is associated with cognitive decline. METHODS: Participants from the Framingham Heart Study without baseline dementia who had ≥ 2 measures of a three-component vitamin B₁₂ indicator (3cB₁₂) and neuropsychological factor scores were included (n = 1994; mean age: 60 years). Adjusted linear mixed effects models estimated annual changes in each factor score between 3cB₁₂ quartiles. Interaction by folate status was also evaluated. RESULTS: Participants in the highest 3cB₁₂ quartile had slower declines in memory, executive function, and language compared to the lowest quartile (memory: β = 0.0071, 95% confidence interval [CI] = 0.003-0.01; executive function: β = 0.0056, 95% CI = 0.0009-0.01; and language: β = 0.0090, 95% CI = 0.004-0.01). Findings were largely robust by folate status (elevated: ≥ 20 ng/mL; non-elevated: 6-19 ng/mL). DISCUSSION: Improving B₁₂ status in dementia-free older adults may help mitigate cognitive decline into later life. HIGHLIGHTS: Higher vitamin B₁₂ status is associated with slower annual cognitive decline. Higher B₁₂ was linked with 0.05 to 0.09 standard deviation less cognitive decline over 10 years. B₁₂ and memory findings are robust for elevated, not non-elevated, folate status.
doi.org/10.1002/alz.70864Open accessPubMed 41152187Populations